Related Experiment Videos
The protein structures that shape caspase activity, specificity, activation and inhibition
Pablo Fuentes-Prior1, Guy S Salvesen
1Abteilung Strukturforschung, Max-Planck-Institut für Biochemie, Am Klopferspitz 18a, D82152, Planegg-Martinsried, Germany. pfuentes@csic-iccc.santpau.es
The Biochemical Journal
|September 29, 2004
Summary
Apoptosis, a programmed cell death pathway, is regulated by proteolysis. Structural insights into caspases, their regulators, and inhibitors reveal novel mechanisms for therapeutic development in diseases involving cell death.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- Apoptosis, or programmed cell death, is a critical biological process regulated by specific limited proteolysis.
- Significant advancements in understanding the structural basis of apoptosis regulation have been made in the last decade.
- The field now possesses substantial structural data covering various stages of apoptosis, including initiators, regulators, executioners, inhibitors, and substrates.
Purpose of the Study:
- To provide a comprehensive review of caspases, their regulators, and inhibitors.
- To consolidate structural and mechanistic insights into the rapidly growing field of apoptosis.
- To highlight the therapeutic potential of understanding apoptosis regulation for degenerative diseases and cancer.
Main Methods:
- Review of existing structural and mechanistic data on caspases, their regulators, and inhibitors.
- Analysis of fundamental protease regulation mechanisms.
- Examination of the structural basis for caspase activation and inhibition strategies.
Main Results:
- The structural understanding of apoptosis regulation is now comparable to well-established proteolytic pathways like the coagulation cascade.
- Novel mechanisms in protease regulation and unusual catalytic mechanisms for caspases have been disclosed.
- Both classic and novel inhibition strategies employed by natural caspase inhibitors have been identified.
Conclusions:
- Structural and mechanistic knowledge of apoptosis pathways is rapidly advancing.
- Caspase activation and inhibition involve diverse and sometimes unexpected mechanisms.
- This knowledge is directly applicable to developing therapeutics for diseases characterized by aberrant apoptosis.